Abstract
We isolated cancer cell–specific phages by subtracting and selecting complex peptide display phage libraries on cultured human cancer cells. The best candidate was selected by performing three rounds of subtraction before each of five selections on the human colorectal WiDr cell line. The phage showed more than 1000-fold higher binding efficiency for WiDr cells when compared to five other human cancer cell lines, including two of colorectal origin, and when compared to wild-type M13 phage. Fifty-fold higher binding efficiency was also seen for a human breast cancer cell line. We show that the WiDr cell binding of the selected phage was efficiently competed by the synthetic peptide HEWSYLAPYPWF, predicted from the phage sequence. This confirms that the specificity of the peptide is independent of the display by the phage coat proteins. The identified peptide may target biomarkers linked to colorectal cancer, and thus be useful for designing gene transfer vectors as well as diagnostic and prognostic tools for this disease.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
St Croix B, Rago C, Velculescu V et al. Genes expressed in human tumor endothelium Science 2000 289: 1197–1202
Pasqualini R . Vascular targeting with phage peptide libraries QJ Nucl Med 1999 43: 159–162
Pasqualini R, Koivunen E, Ruoslahti E . Alpha v integrins as receptors for tumor targeting by circulating ligands Nat Biotechnol 1997 15: 542–546
Yip YL, Hawkins NJ, Smith G et al. Biodistribution of filamentous phage-Fab in nude mice J Immunol Methods 1999 225: 171–178
Nicklin SA, White SJ, Watkins SJ et al. Selective targeting of gene transfer to vascular endothelial cells by use of peptides isolated by phage display Circulation 2000 102: 231–237
Poul MA, Becerril B, Nielsen UB et al. Selection of tumor-specific internalizing human antibodies from phage libraries JMol Biol 2000 301: 1149–1161
Ridgway JB, Ng E, Kern JA et al. Identification of a human anti-CD55 single-chain Fv by subtractive panning of a phage library using tumor and nontumor cell lines Cancer Res 1999 59: 2718–2723
Barry MA, Dower WJ, Johnston SA . Toward cell-targeting gene therapy vectors: selection of cell-binding peptides from random peptide-presenting phage libraries Nat Med 1996 2: 299–305
Johns M, George AJ, Ritter MA . In vivo selection of sFv from phage display libraries J Immunol Methods 2000 239: 137–151
Samoylova TI, Smith BF . Elucidation of muscle-binding peptides by phage display screening Muscle Nerve 1999 22: 460–466
Arap W, Pasqualini R, Ruoslahti E . Cancer treatment by targeted drug delivery to tumor vasculature in a mouse model Science 1998 279: 377–380
Rajotte D, Arap W, Hagedorn M et al. Molecular heterogeneity of the vascular endothelium revealed by in vivo phage display J Clin Invest 1998 102: 430–437
Van Ewijk W, de Kruif J, Germeraad WT et al. Subtractive isolation of phage-displayed single-chain antibodies to thymic stromal cells by using intact thymic fragments Proc Natl Acad Sci USA 1997 94: 3903–3908
Harbottle RP, Cooper RG, Hart SL et al. An RGD-oligolysine peptide: a prototype construct for integrin-mediated gene delivery Hum Gene Ther 1998 9: 1037–1047
Jiang H, Cooper B, Robey FA et al. DNA binds and activates complement via residues 14–26 of the human C1q A chain Biol Chem 1992 267: 25597–25601
Park BW, Zhang HT, Wu C et al. Rationally designed anti-HER2/neu peptide mimetic disables P185HER2/neu tyro-sine kinases in vitro and in vivo Nat Biotechnol 2000 18: 194–198
Peng KW, Russell SJ . Viral vector targeting Curr Opin Biotechnol 1999 10: 454–457
Spear MA, Breakefield XA, Beltzer J et al. Isolation, characterization, and recovery of small peptide phage display epitopes selected against viable malignant glioma cells Cancer Gene Ther 2001 7: 506–511
Acknowledgements
The technical assistance by Dalila Ali-Hadji, Vincent Romanet, Virginie Nourtier, David Bock, Anita Spindler, and Dominique Villeval is highly appreciated.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Rasmussen, U., Schreiber, V., Schultz, H. et al. Tumor cell-targeting by phage-displayed peptides. Cancer Gene Ther 9, 606–612 (2002). https://doi.org/10.1038/sj.cgt.7700476
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.cgt.7700476
Keywords
This article is cited by
-
Bacteriophages: cancer diagnosis, treatment, and future prospects
Journal of Pharmaceutical Investigation (2021)
-
Selection and Characterization of Tenascin C Targeting Peptide
Molecules and Cells (2012)
-
Targeting of adenovirus vectors carrying a tumor cell-specific peptide: in vitro and in vivo studies
Cancer Gene Therapy (2007)